nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—ALB—melanoma	0.157	0.512	CbGaD
Pitavastatin—ORM1—Vemurafenib—melanoma	0.155	0.282	CbGbCtD
Pitavastatin—ABCB1—melanoma	0.15	0.488	CbGaD
Pitavastatin—ABCG2—Vemurafenib—melanoma	0.0947	0.172	CbGbCtD
Pitavastatin—SLCO1B3—Docetaxel—melanoma	0.0702	0.127	CbGbCtD
Pitavastatin—ALB—Vemurafenib—melanoma	0.0653	0.118	CbGbCtD
Pitavastatin—ABCG2—Dactinomycin—melanoma	0.0629	0.114	CbGbCtD
Pitavastatin—ABCC2—Docetaxel—melanoma	0.0359	0.0652	CbGbCtD
Pitavastatin—ABCG2—Docetaxel—melanoma	0.0325	0.059	CbGbCtD
Pitavastatin—ABCB1—Dactinomycin—melanoma	0.0227	0.0412	CbGbCtD
Pitavastatin—ABCB1—Docetaxel—melanoma	0.0117	0.0213	CbGbCtD
Pitavastatin—Interstitial lung disease—Bleomycin—melanoma	0.00157	0.0313	CcSEcCtD
Pitavastatin—Interstitial lung disease—Carmustine—melanoma	0.00137	0.0273	CcSEcCtD
Pitavastatin—Myopathy—Temozolomide—melanoma	0.00133	0.0266	CcSEcCtD
Pitavastatin—Pain in extremity—Vemurafenib—melanoma	0.00133	0.0265	CcSEcCtD
Pitavastatin—Interstitial lung disease—Temozolomide—melanoma	0.00132	0.0264	CcSEcCtD
Pitavastatin—Memory impairment—Temozolomide—melanoma	0.00119	0.0238	CcSEcCtD
Pitavastatin—Interstitial lung disease—Docetaxel—melanoma	0.000879	0.0175	CcSEcCtD
Pitavastatin—Hepatic failure—Dactinomycin—melanoma	0.000835	0.0167	CcSEcCtD
Pitavastatin—Back pain—Vemurafenib—melanoma	0.000774	0.0155	CcSEcCtD
Pitavastatin—Hepatic failure—Temozolomide—melanoma	0.000756	0.0151	CcSEcCtD
Pitavastatin—Amnesia—Carmustine—melanoma	0.000748	0.0149	CcSEcCtD
Pitavastatin—Amnesia—Temozolomide—melanoma	0.000723	0.0144	CcSEcCtD
Pitavastatin—Arthralgia—Vemurafenib—melanoma	0.000681	0.0136	CcSEcCtD
Pitavastatin—Myalgia—Vemurafenib—melanoma	0.000681	0.0136	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000595	0.0119	CcSEcCtD
Pitavastatin—Fatigue—Vemurafenib—melanoma	0.000563	0.0112	CcSEcCtD
Pitavastatin—Constipation—Vemurafenib—melanoma	0.000558	0.0112	CcSEcCtD
Pitavastatin—Hypoaesthesia—Bleomycin—melanoma	0.000554	0.0111	CcSEcCtD
Pitavastatin—Erectile dysfunction—Temozolomide—melanoma	0.000541	0.0108	CcSEcCtD
Pitavastatin—Hepatitis—Dactinomycin—melanoma	0.000519	0.0104	CcSEcCtD
Pitavastatin—Hepatic failure—Docetaxel—melanoma	0.000503	0.01	CcSEcCtD
Pitavastatin—Hypoaesthesia—Carmustine—melanoma	0.000484	0.00966	CcSEcCtD
Pitavastatin—Hypersensitivity—Vemurafenib—melanoma	0.000481	0.00961	CcSEcCtD
Pitavastatin—Hepatitis—Temozolomide—melanoma	0.00047	0.00938	CcSEcCtD
Pitavastatin—Asthenia—Vemurafenib—melanoma	0.000469	0.00936	CcSEcCtD
Pitavastatin—Hypoaesthesia—Temozolomide—melanoma	0.000467	0.00933	CcSEcCtD
Pitavastatin—Pruritus—Vemurafenib—melanoma	0.000462	0.00923	CcSEcCtD
Pitavastatin—Pain in extremity—Docetaxel—melanoma	0.000452	0.00902	CcSEcCtD
Pitavastatin—Ill-defined disorder—Bleomycin—melanoma	0.00045	0.00898	CcSEcCtD
Pitavastatin—Diarrhoea—Vemurafenib—melanoma	0.000447	0.00892	CcSEcCtD
Pitavastatin—Malaise—Bleomycin—melanoma	0.000437	0.00873	CcSEcCtD
Pitavastatin—Dizziness—Vemurafenib—melanoma	0.000432	0.00862	CcSEcCtD
Pitavastatin—Ill-defined disorder—Dactinomycin—melanoma	0.00042	0.00838	CcSEcCtD
Pitavastatin—Myalgia—Bleomycin—melanoma	0.000413	0.00824	CcSEcCtD
Pitavastatin—Rash—Vemurafenib—melanoma	0.000412	0.00822	CcSEcCtD
Pitavastatin—Dermatitis—Vemurafenib—melanoma	0.000411	0.00821	CcSEcCtD
Pitavastatin—Back pain—Carmustine—melanoma	0.000409	0.00817	CcSEcCtD
Pitavastatin—Headache—Vemurafenib—melanoma	0.000409	0.00817	CcSEcCtD
Pitavastatin—Discomfort—Bleomycin—melanoma	0.000408	0.00814	CcSEcCtD
Pitavastatin—Malaise—Dactinomycin—melanoma	0.000408	0.00814	CcSEcCtD
Pitavastatin—Nasopharyngitis—Docetaxel—melanoma	0.000404	0.00806	CcSEcCtD
Pitavastatin—Confusional state—Bleomycin—melanoma	0.000399	0.00797	CcSEcCtD
Pitavastatin—Back pain—Temozolomide—melanoma	0.000396	0.0079	CcSEcCtD
Pitavastatin—Nausea—Vemurafenib—melanoma	0.000388	0.00775	CcSEcCtD
Pitavastatin—Myalgia—Dactinomycin—melanoma	0.000385	0.00769	CcSEcCtD
Pitavastatin—Discomfort—Dactinomycin—melanoma	0.00038	0.00759	CcSEcCtD
Pitavastatin—Ill-defined disorder—Temozolomide—melanoma	0.000379	0.00758	CcSEcCtD
Pitavastatin—Malaise—Temozolomide—melanoma	0.000369	0.00736	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Bleomycin—melanoma	0.00036	0.0072	CcSEcCtD
Pitavastatin—Myalgia—Carmustine—melanoma	0.00036	0.00719	CcSEcCtD
Pitavastatin—Confusional state—Carmustine—melanoma	0.000348	0.00695	CcSEcCtD
Pitavastatin—Arthralgia—Temozolomide—melanoma	0.000348	0.00695	CcSEcCtD
Pitavastatin—Myalgia—Temozolomide—melanoma	0.000348	0.00695	CcSEcCtD
Pitavastatin—Discomfort—Temozolomide—melanoma	0.000344	0.00687	CcSEcCtD
Pitavastatin—Jaundice—Docetaxel—melanoma	0.000339	0.00677	CcSEcCtD
Pitavastatin—Confusional state—Temozolomide—melanoma	0.000337	0.00672	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000336	0.00671	CcSEcCtD
Pitavastatin—Feeling abnormal—Bleomycin—melanoma	0.000326	0.00651	CcSEcCtD
Pitavastatin—Fatigue—Dactinomycin—melanoma	0.000318	0.00635	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Carmustine—melanoma	0.000315	0.00628	CcSEcCtD
Pitavastatin—Urticaria—Bleomycin—melanoma	0.000314	0.00628	CcSEcCtD
Pitavastatin—Hepatitis—Docetaxel—melanoma	0.000312	0.00624	CcSEcCtD
Pitavastatin—Insomnia—Carmustine—melanoma	0.000312	0.00624	CcSEcCtD
Pitavastatin—Hypoaesthesia—Docetaxel—melanoma	0.000311	0.00621	CcSEcCtD
Pitavastatin—Feeling abnormal—Dactinomycin—melanoma	0.000304	0.00607	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000304	0.00607	CcSEcCtD
Pitavastatin—Insomnia—Temozolomide—melanoma	0.000302	0.00603	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Dactinomycin—melanoma	0.000302	0.00602	CcSEcCtD
Pitavastatin—Constipation—Carmustine—melanoma	0.000295	0.0059	CcSEcCtD
Pitavastatin—Dyspepsia—Temozolomide—melanoma	0.000294	0.00587	CcSEcCtD
Pitavastatin—Abdominal pain—Dactinomycin—melanoma	0.000292	0.00582	CcSEcCtD
Pitavastatin—Hypersensitivity—Bleomycin—melanoma	0.000292	0.00582	CcSEcCtD
Pitavastatin—Fatigue—Temozolomide—melanoma	0.000288	0.00575	CcSEcCtD
Pitavastatin—Constipation—Temozolomide—melanoma	0.000285	0.0057	CcSEcCtD
Pitavastatin—Feeling abnormal—Carmustine—melanoma	0.000285	0.00568	CcSEcCtD
Pitavastatin—Asthenia—Bleomycin—melanoma	0.000284	0.00567	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Carmustine—melanoma	0.000282	0.00564	CcSEcCtD
Pitavastatin—Pruritus—Bleomycin—melanoma	0.00028	0.00559	CcSEcCtD
Pitavastatin—Feeling abnormal—Temozolomide—melanoma	0.000275	0.00549	CcSEcCtD
Pitavastatin—Abdominal pain—Carmustine—melanoma	0.000273	0.00545	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Temozolomide—melanoma	0.000273	0.00545	CcSEcCtD
Pitavastatin—Hypersensitivity—Dactinomycin—melanoma	0.000272	0.00543	CcSEcCtD
Pitavastatin—Urticaria—Temozolomide—melanoma	0.000265	0.00529	CcSEcCtD
Pitavastatin—Asthenia—Dactinomycin—melanoma	0.000265	0.00529	CcSEcCtD
Pitavastatin—Abdominal pain—Temozolomide—melanoma	0.000264	0.00527	CcSEcCtD
Pitavastatin—Back pain—Docetaxel—melanoma	0.000263	0.00525	CcSEcCtD
Pitavastatin—Muscle spasms—Docetaxel—melanoma	0.000261	0.00522	CcSEcCtD
Pitavastatin—Hypersensitivity—Carmustine—melanoma	0.000254	0.00508	CcSEcCtD
Pitavastatin—Diarrhoea—Dactinomycin—melanoma	0.000252	0.00504	CcSEcCtD
Pitavastatin—Rash—Bleomycin—melanoma	0.000249	0.00498	CcSEcCtD
Pitavastatin—Dermatitis—Bleomycin—melanoma	0.000249	0.00498	CcSEcCtD
Pitavastatin—Asthenia—Carmustine—melanoma	0.000248	0.00495	CcSEcCtD
Pitavastatin—Hypersensitivity—Temozolomide—melanoma	0.000246	0.00491	CcSEcCtD
Pitavastatin—Asthenia—Temozolomide—melanoma	0.000239	0.00478	CcSEcCtD
Pitavastatin—Diarrhoea—Carmustine—melanoma	0.000236	0.00472	CcSEcCtD
Pitavastatin—Pruritus—Temozolomide—melanoma	0.000236	0.00471	CcSEcCtD
Pitavastatin—Nausea—Bleomycin—melanoma	0.000235	0.00469	CcSEcCtD
Pitavastatin—Rash—Dactinomycin—melanoma	0.000233	0.00465	CcSEcCtD
Pitavastatin—Myalgia—Docetaxel—melanoma	0.000232	0.00462	CcSEcCtD
Pitavastatin—Arthralgia—Docetaxel—melanoma	0.000232	0.00462	CcSEcCtD
Pitavastatin—Dizziness—Carmustine—melanoma	0.000228	0.00456	CcSEcCtD
Pitavastatin—Diarrhoea—Temozolomide—melanoma	0.000228	0.00456	CcSEcCtD
Pitavastatin—Confusional state—Docetaxel—melanoma	0.000224	0.00447	CcSEcCtD
Pitavastatin—Dizziness—Temozolomide—melanoma	0.000221	0.00441	CcSEcCtD
Pitavastatin—Rosuvastatin—ALB—melanoma	0.000221	0.598	CrCbGaD
Pitavastatin—Nausea—Dactinomycin—melanoma	0.000219	0.00438	CcSEcCtD
Pitavastatin—Rash—Carmustine—melanoma	0.000218	0.00435	CcSEcCtD
Pitavastatin—Dermatitis—Carmustine—melanoma	0.000218	0.00434	CcSEcCtD
Pitavastatin—Headache—Carmustine—melanoma	0.000216	0.00432	CcSEcCtD
Pitavastatin—Rash—Temozolomide—melanoma	0.00021	0.0042	CcSEcCtD
Pitavastatin—Dermatitis—Temozolomide—melanoma	0.00021	0.0042	CcSEcCtD
Pitavastatin—Headache—Temozolomide—melanoma	0.000209	0.00417	CcSEcCtD
Pitavastatin—Nausea—Carmustine—melanoma	0.000205	0.0041	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000202	0.00404	CcSEcCtD
Pitavastatin—Insomnia—Docetaxel—melanoma	0.000201	0.00401	CcSEcCtD
Pitavastatin—Nausea—Temozolomide—melanoma	0.000198	0.00396	CcSEcCtD
Pitavastatin—Dyspepsia—Docetaxel—melanoma	0.000195	0.0039	CcSEcCtD
Pitavastatin—Fatigue—Docetaxel—melanoma	0.000191	0.00382	CcSEcCtD
Pitavastatin—Constipation—Docetaxel—melanoma	0.00019	0.00379	CcSEcCtD
Pitavastatin—Feeling abnormal—Docetaxel—melanoma	0.000183	0.00365	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Docetaxel—melanoma	0.000181	0.00362	CcSEcCtD
Pitavastatin—Abdominal pain—Docetaxel—melanoma	0.000175	0.0035	CcSEcCtD
Pitavastatin—Hypersensitivity—Docetaxel—melanoma	0.000164	0.00327	CcSEcCtD
Pitavastatin—Asthenia—Docetaxel—melanoma	0.000159	0.00318	CcSEcCtD
Pitavastatin—Pruritus—Docetaxel—melanoma	0.000157	0.00314	CcSEcCtD
Pitavastatin—Diarrhoea—Docetaxel—melanoma	0.000152	0.00303	CcSEcCtD
Pitavastatin—Atorvastatin—ABCB1—melanoma	0.000148	0.402	CrCbGaD
Pitavastatin—Dizziness—Docetaxel—melanoma	0.000147	0.00293	CcSEcCtD
Pitavastatin—Rash—Docetaxel—melanoma	0.00014	0.00279	CcSEcCtD
Pitavastatin—Dermatitis—Docetaxel—melanoma	0.00014	0.00279	CcSEcCtD
Pitavastatin—Headache—Docetaxel—melanoma	0.000139	0.00278	CcSEcCtD
Pitavastatin—Nausea—Docetaxel—melanoma	0.000132	0.00263	CcSEcCtD
Pitavastatin—ALB—Metabolism—BSG—melanoma	1.37e-05	0.00015	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	1.37e-05	0.000149	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PIK3CB—melanoma	1.36e-05	0.000149	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—SLC5A5—melanoma	1.36e-05	0.000149	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—MTAP—melanoma	1.35e-05	0.000148	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PTGS2—melanoma	1.35e-05	0.000147	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—ITGB3—melanoma	1.34e-05	0.000147	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PRKCA—melanoma	1.34e-05	0.000147	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	1.33e-05	0.000146	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GPAM—melanoma	1.33e-05	0.000146	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	1.33e-05	0.000146	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GPAM—melanoma	1.33e-05	0.000145	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	1.32e-05	0.000145	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.32e-05	0.000145	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GNAQ—melanoma	1.31e-05	0.000144	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CD44—melanoma	1.31e-05	0.000144	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GNA11—melanoma	1.31e-05	0.000143	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—LUM—melanoma	1.29e-05	0.000141	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PHGDH—melanoma	1.29e-05	0.000141	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.28e-05	0.000141	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—ALB—melanoma	1.28e-05	0.00014	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PRKCA—melanoma	1.28e-05	0.00014	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—FASN—melanoma	1.28e-05	0.00014	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.27e-05	0.000139	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PIK3CD—melanoma	1.27e-05	0.000139	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ERCC2—melanoma	1.27e-05	0.000139	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—HPSE—melanoma	1.26e-05	0.000138	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	1.26e-05	0.000138	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CYP1B1—melanoma	1.26e-05	0.000138	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—SLC5A5—melanoma	1.26e-05	0.000138	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—ALB—melanoma	1.26e-05	0.000137	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—RAC1—melanoma	1.25e-05	0.000136	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CUBN—melanoma	1.24e-05	0.000136	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	1.22e-05	0.000134	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CD44—melanoma	1.22e-05	0.000133	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GNAQ—melanoma	1.22e-05	0.000133	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—MMP1—melanoma	1.21e-05	0.000132	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—LUM—melanoma	1.2e-05	0.000132	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PHGDH—melanoma	1.2e-05	0.000132	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.2e-05	0.000132	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SDHD—melanoma	1.2e-05	0.000131	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—BSG—melanoma	1.2e-05	0.000131	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CSPG4—melanoma	1.2e-05	0.000131	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—CDK2—melanoma	1.18e-05	0.000129	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—HPSE—melanoma	1.18e-05	0.000129	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CG—melanoma	1.18e-05	0.000129	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PTEN—melanoma	1.18e-05	0.000129	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.17e-05	0.000128	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYP1B1—melanoma	1.16e-05	0.000127	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GPAM—melanoma	1.16e-05	0.000127	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CUBN—melanoma	1.16e-05	0.000127	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	1.16e-05	0.000126	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PPARG—melanoma	1.14e-05	0.000125	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.14e-05	0.000124	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PLA2G6—melanoma	1.13e-05	0.000124	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PLA2G6—melanoma	1.13e-05	0.000123	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SDHD—melanoma	1.12e-05	0.000123	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—BSG—melanoma	1.12e-05	0.000123	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CSPG4—melanoma	1.12e-05	0.000123	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CG—melanoma	1.11e-05	0.000122	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.11e-05	0.000121	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PIK3CB—melanoma	1.11e-05	0.000121	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.11e-05	0.000121	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—FN1—melanoma	1.1e-05	0.00012	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	1.1e-05	0.00012	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PTGS2—melanoma	1.1e-05	0.00012	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—NOS2—melanoma	1.09e-05	0.000119	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GPAM—melanoma	1.08e-05	0.000119	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.08e-05	0.000118	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.08e-05	0.000118	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PPARG—melanoma	1.07e-05	0.000117	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CG—melanoma	1.05e-05	0.000115	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—EGF—melanoma	1.04e-05	0.000114	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CD—melanoma	1.04e-05	0.000113	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ABCB1—melanoma	1.04e-05	0.000113	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.03e-05	0.000113	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ALB—melanoma	1.02e-05	0.000112	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.02e-05	0.000112	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—VCAN—melanoma	1.02e-05	0.000111	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—VCAN—melanoma	1.01e-05	0.000111	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CG—melanoma	1e-05	0.00011	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PLA2G6—melanoma	9.87e-06	0.000108	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CD—melanoma	9.77e-06	0.000107	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PPARG—melanoma	9.68e-06	0.000106	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ALB—melanoma	9.65e-06	0.000106	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.64e-06	0.000105	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IGF1—melanoma	9.64e-06	0.000105	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ABCB1—melanoma	9.59e-06	0.000105	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.58e-06	0.000105	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PTEN—melanoma	9.58e-06	0.000105	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	9.54e-06	0.000104	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PRKCA—melanoma	9.53e-06	0.000104	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ERCC2—melanoma	9.46e-06	0.000103	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	9.39e-06	0.000103	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.3e-06	0.000102	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CD—melanoma	9.25e-06	0.000101	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.25e-06	0.000101	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PLA2G6—melanoma	9.22e-06	0.000101	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	9.08e-06	9.94e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CB—melanoma	9.04e-06	9.89e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTGS2—melanoma	8.96e-06	9.8e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—VCAN—melanoma	8.87e-06	9.7e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PRKCA—melanoma	8.83e-06	9.66e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CD—melanoma	8.82e-06	9.65e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ERCC2—melanoma	8.76e-06	9.58e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ALB—melanoma	8.7e-06	9.52e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP17A1—melanoma	8.59e-06	9.4e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP17A1—melanoma	8.54e-06	9.34e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CB—melanoma	8.52e-06	9.32e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.47e-06	9.27e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTGS2—melanoma	8.44e-06	9.23e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.42e-06	9.22e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	8.36e-06	9.15e-05	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PIK3CA—melanoma	8.29e-06	9.07e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—VCAN—melanoma	8.29e-06	9.07e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GNA11—melanoma	8.11e-06	8.88e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GNA11—melanoma	8.06e-06	8.82e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CB—melanoma	8.06e-06	8.82e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—FASN—melanoma	7.94e-06	8.69e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—FASN—melanoma	7.89e-06	8.64e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	7.84e-06	8.58e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.83e-06	8.57e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTEN—melanoma	7.81e-06	8.55e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SLC5A5—melanoma	7.81e-06	8.54e-05	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	7.79e-06	8.53e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SLC5A5—melanoma	7.76e-06	8.49e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CB—melanoma	7.69e-06	8.41e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	7.67e-06	8.39e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTGS2—melanoma	7.61e-06	8.33e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	7.57e-06	8.28e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GNAQ—melanoma	7.54e-06	8.25e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CD44—melanoma	7.54e-06	8.25e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GNAQ—melanoma	7.5e-06	8.2e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CD44—melanoma	7.5e-06	8.2e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP17A1—melanoma	7.48e-06	8.19e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CG—melanoma	7.47e-06	8.17e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IL2—melanoma	7.41e-06	8.1e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.38e-06	8.08e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTEN—melanoma	7.36e-06	8.05e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.34e-06	8.03e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.32e-06	8.01e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.27e-06	7.96e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP1B1—melanoma	7.23e-06	7.91e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PPARG—melanoma	7.21e-06	7.89e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP1B1—melanoma	7.19e-06	7.87e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GNA11—melanoma	7.07e-06	7.73e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP17A1—melanoma	6.99e-06	7.65e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	6.93e-06	7.58e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—FASN—melanoma	6.92e-06	7.57e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CG—melanoma	6.92e-06	7.57e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.89e-06	7.54e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	6.81e-06	7.45e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SLC5A5—melanoma	6.8e-06	7.44e-05	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—AKT1—melanoma	6.77e-06	7.41e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PIK3CA—melanoma	6.76e-06	7.4e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PPARG—melanoma	6.67e-06	7.3e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTEN—melanoma	6.64e-06	7.27e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GNA11—melanoma	6.6e-06	7.22e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GNAQ—melanoma	6.57e-06	7.19e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CD44—melanoma	6.57e-06	7.19e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CD—melanoma	6.57e-06	7.18e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ALB—melanoma	6.48e-06	7.09e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—FASN—melanoma	6.46e-06	7.07e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.38e-06	6.98e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SLC5A5—melanoma	6.35e-06	6.95e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.34e-06	6.94e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP1B1—melanoma	6.3e-06	6.89e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—VEGFA—melanoma	6.29e-06	6.89e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—NRAS—melanoma	6.22e-06	6.8e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GNAQ—melanoma	6.14e-06	6.72e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CD44—melanoma	6.14e-06	6.72e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CD—melanoma	6.08e-06	6.65e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.01e-06	6.58e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ALB—melanoma	6e-06	6.57e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.95e-06	6.52e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—MAPK3—melanoma	5.95e-06	6.52e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ABCB1—melanoma	5.95e-06	6.51e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ABCB1—melanoma	5.92e-06	6.48e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP1B1—melanoma	5.88e-06	6.44e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CB—melanoma	5.72e-06	6.26e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTGS2—melanoma	5.67e-06	6.2e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—MAPK1—melanoma	5.67e-06	6.2e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—AKT1—melanoma	5.52e-06	6.04e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CA—melanoma	5.51e-06	6.03e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PRKCA—melanoma	5.48e-06	6e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PRKCA—melanoma	5.45e-06	5.96e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ERCC2—melanoma	5.43e-06	5.95e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ERCC2—melanoma	5.4e-06	5.91e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—KRAS—melanoma	5.35e-06	5.85e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CB—melanoma	5.3e-06	5.8e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTGS2—melanoma	5.25e-06	5.74e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.19e-06	5.68e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CA—melanoma	5.19e-06	5.68e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTEN—melanoma	4.94e-06	5.41e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CA—melanoma	4.92e-06	5.38e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ABCB1—melanoma	4.85e-06	5.3e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PRKCA—melanoma	4.77e-06	5.22e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TP53—melanoma	4.76e-06	5.2e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ERCC2—melanoma	4.73e-06	5.18e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CA—melanoma	4.68e-06	5.13e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTEN—melanoma	4.58e-06	5.01e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—HRAS—melanoma	4.55e-06	4.98e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.5e-06	4.93e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—AKT1—melanoma	4.5e-06	4.93e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.48e-06	4.9e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PRKCA—melanoma	4.46e-06	4.88e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ERCC2—melanoma	4.42e-06	4.84e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CG—melanoma	4.29e-06	4.7e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CG—melanoma	4.27e-06	4.67e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—AKT1—melanoma	4.24e-06	4.64e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PPARG—melanoma	4.14e-06	4.53e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PPARG—melanoma	4.12e-06	4.51e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—AKT1—melanoma	4.02e-06	4.39e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—AKT1—melanoma	3.83e-06	4.19e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CD—melanoma	3.77e-06	4.13e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CD—melanoma	3.75e-06	4.1e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CG—melanoma	3.74e-06	4.09e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ALB—melanoma	3.72e-06	4.08e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.66e-06	4.01e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PPARG—melanoma	3.61e-06	3.95e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CG—melanoma	3.49e-06	3.82e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CA—melanoma	3.49e-06	3.82e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PPARG—melanoma	3.37e-06	3.69e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CB—melanoma	3.29e-06	3.6e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CD—melanoma	3.29e-06	3.6e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CB—melanoma	3.27e-06	3.58e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTGS2—melanoma	3.26e-06	3.57e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALB—melanoma	3.24e-06	3.55e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTGS2—melanoma	3.24e-06	3.54e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CA—melanoma	3.23e-06	3.53e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CD—melanoma	3.07e-06	3.36e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALB—melanoma	3.03e-06	3.32e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CB—melanoma	2.86e-06	3.13e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AKT1—melanoma	2.85e-06	3.12e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTEN—melanoma	2.84e-06	3.11e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTGS2—melanoma	2.84e-06	3.11e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTEN—melanoma	2.83e-06	3.09e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CB—melanoma	2.68e-06	2.93e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTGS2—melanoma	2.65e-06	2.9e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AKT1—melanoma	2.64e-06	2.89e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTEN—melanoma	2.48e-06	2.71e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTEN—melanoma	2.31e-06	2.53e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CA—melanoma	2e-06	2.19e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CA—melanoma	1.99e-06	2.18e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CA—melanoma	1.75e-06	1.91e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AKT1—melanoma	1.64e-06	1.79e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CA—melanoma	1.63e-06	1.79e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AKT1—melanoma	1.63e-06	1.78e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AKT1—melanoma	1.43e-06	1.56e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AKT1—melanoma	1.33e-06	1.46e-05	CbGpPWpGaD
